INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 204 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212,079 | -60.4% | 11,439 | -76.4% | 0.00% | -71.4% |
| Q2 2023 | $536,156 | +224.9% | 48,477 | +294.5% | 0.01% | +250.0% |
| Q1 2023 | $165,028 | +17.5% | 12,288 | +8.2% | 0.00% | 0.0% |
| Q4 2022 | $140,437 | -64.6% | 11,353 | -80.0% | 0.00% | -50.0% |
| Q3 2022 | $396,396 | +93.4% | 56,840 | +282.9% | 0.00% | 0.0% |
| Q2 2022 | $205,000 | -93.4% | 14,844 | -89.0% | 0.00% | -88.6% |
| Q1 2021 | $3,117,000 | +423.9% | 135,032 | +460.3% | 0.04% | +600.0% |
| Q4 2020 | $595,000 | -58.5% | 24,100 | -30.3% | 0.01% | -82.8% |
| Q3 2020 | $1,435,000 | +580.1% | 34,600 | +686.4% | 0.03% | +314.3% |
| Q2 2020 | $211,000 | -34.5% | 4,400 | +69.2% | 0.01% | +16.7% |
| Q4 2019 | $322,000 | +56.3% | 2,600 | +0.5% | 0.01% | 0.0% |
| Q2 2019 | $206,000 | -86.3% | 2,588 | -78.3% | 0.01% | -88.9% |
| Q3 2018 | $1,504,000 | +90.6% | 11,900 | +26.6% | 0.05% | +12.5% |
| Q2 2018 | $789,000 | +101.8% | 9,400 | +295.3% | 0.05% | +14.3% |
| Q3 2016 | $391,000 | -3.9% | 2,378 | +64.9% | 0.04% | -10.6% |
| Q1 2015 | $407,000 | -32.1% | 1,442 | -43.0% | 0.05% | -44.7% |
| Q3 2014 | $599,000 | – | 2,529 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |